{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:25:37Z","timestamp":1786116337092,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["R21 20231130"],"award-info":[{"award-number":["R21 20231130"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03315-2","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:31:50Z","timestamp":1779085910000},"page":"1393-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Platelet Fc\u0263RIIa: a novel biomarker of risk for thromboembolism and death in cancer"],"prefix":"10.1007","volume":"59","clinical-trial-number":[{"clinical-trial-number":"nct05240508","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Chris E.","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi S.","family":"Taatjes-Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi E.","family":"Sai-Hardebeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Callas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikechukwu","family":"Chidobem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"3315_CR1","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1158\/0008-5472.CAN-15-3100","volume":"76","author":"NS Key","year":"2016","unstructured":"Key NS, Khorana AA, Mackman N, McCarty OJ, White GC, Francis CW, McCrae KR, Palumbo JS, Raskob GE, Chan AT, Sood AK (2016) Thrombosis in cancer: Research priorities identified by a National Cancer Institute\/National Heart, Lung, and Blood Institute Strategic Working Group. Cancer Res 76:3671\u20133675","journal-title":"Cancer Res"},{"key":"3315_CR2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","volume":"70","author":"BB Navi","year":"2017","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM (2017) Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 70:926\u2013938","journal-title":"J Am Coll Cardiol"},{"issue":"03","key":"3315_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(03):632\u2013634","journal-title":"J Thromb Haemost"},{"key":"3315_CR4","first-page":"57","volume":"117","author":"AT Cohen","year":"2016","unstructured":"Cohen AT, Katholing A, Rietbrock S, Bamber L, Martinez C (2016) Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. Thromb Haemost 117:57\u201365","journal-title":"Thromb Haemost"},{"key":"3315_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10100380","volume":"10","author":"NB Abdol Razak","year":"2018","unstructured":"Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P (2018) Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment. Cancers (Basel) 10:380","journal-title":"Cancers (Basel)"},{"key":"3315_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s13402-023-00773-1","volume":"46","author":"Q Shi","year":"2023","unstructured":"Shi Q, Ji T, Tang X et al (2023) The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis. Cell Oncol 46:521\u2013532","journal-title":"Cell Oncol"},{"key":"3315_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1182\/blood-2013-03-492447","volume":"123","author":"A Mitrugno","year":"2014","unstructured":"Mitrugno A, Williams D, Kerrigan SW, Moran N (2014) A novel and essential role for Fc\u03b3RIIa in cancer cell-induced platelet activation. Blood 123:249\u2013260","journal-title":"Blood"},{"key":"3315_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","volume":"33","author":"GH Lyman","year":"2015","unstructured":"Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A (2015) American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014. J Clin Oncol 33:654\u2013656","journal-title":"J Clin Oncol"},{"key":"3315_CR9","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","volume":"20","author":"D Farge","year":"2019","unstructured":"Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J (2019) International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol 20:e566\u2013e581","journal-title":"Lancet Oncol"},{"key":"3315_CR10","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902\u20134907","journal-title":"Blood"},{"key":"3315_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100038","volume":"7","author":"S Ades","year":"2023","unstructured":"Ades S, Holmes CE (2023) Implementing guidelines to prevent cancer associated thrombosis: how can we do better? Res Pract Thromb Haemost 7:e100038. https:\/\/doi.org\/10.1016\/j.rpth.2023.100038","journal-title":"Res Pract Thromb Haemost"},{"key":"3315_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jacc.2018.04.046","volume":"72","author":"DJ Schneider","year":"2018","unstructured":"Schneider DJ, McMahon SR, Chava S, Taatjes-Sommer HS, Meagher S, Ehle GL, Brummel-Ziedins KE (2018) Fc\u03b3RIIa: a new cardiovascular risk marker. J Am Coll Cardiol 72:237\u2013238","journal-title":"J Am Coll Cardiol"},{"key":"3315_CR13","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.jacc.2024.08.051","volume":"84","author":"DJ Schneider","year":"2024","unstructured":"Schneider DJ, McMahon SR, Angiolillo DJ, Fanaroff A, Ibrahim H, Hohl PK, Wanamaker BL, Effron MB, DiBattiste PM (2024) Platelet Fc\u03b3RIIa as a marker of cardiovascular risk after myocardial infarction. J Am Coll Cardiol 84:1721\u20131729","journal-title":"J Am Coll Cardiol"},{"key":"3315_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1182\/blood.V60.6.1277.1277","volume":"60","author":"SP Karas","year":"1982","unstructured":"Karas SP, Rosse WF, Kurlander RJ (1982) Characterization of the IgG-Fc receptor on human platelets. Blood 60:1277\u20131282","journal-title":"Blood"},{"key":"3315_CR15","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1182\/blood-2008-02-142125","volume":"112","author":"B Boylan","year":"2008","unstructured":"Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ (2008) Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood 112:2780\u20132786","journal-title":"Blood"},{"issue":"14","key":"3315_CR16","doi-asserted-by":"publisher","first-page":"12009","DOI":"10.1074\/jbc.M111803200","volume":"277","author":"P Lova","year":"2002","unstructured":"Lova P, Paganini S, Sinigaglia F, Balduini C, Torti M (2002) A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 277(14):12009\u201312015","journal-title":"J Biol Chem"},{"key":"3315_CR17","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1182\/blood-2012-07-443325","volume":"121","author":"H Zhi","year":"2013","unstructured":"Zhi H, Rauova L, Hayes V et al (2013) Cooperative integrin\/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood 121:1858\u20131867","journal-title":"Blood"},{"issue":"5","key":"3315_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/jth.15265","volume":"19","author":"P Patel","year":"2021","unstructured":"Patel P, Michael JV, Naik UP, McKenzie SE (2021) Platelet Fc\u03b3RIIA in immunity and thrombosis: adaptive immunothrombosis. J Thromb Haemost 19(5):1149\u20131160","journal-title":"J Thromb Haemost"},{"key":"3315_CR19","doi-asserted-by":"publisher","first-page":"1282637","DOI":"10.3389\/fcvm.2023.1282637","volume":"10","author":"M Abdelouahed","year":"2023","unstructured":"Abdelouahed M, Yateem D, Fredericks S (2023) Fc\u03b3RIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation. Front Cardiovasc Med 10:1282637","journal-title":"Front Cardiovasc Med"},{"issue":"21","key":"3315_CR20","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.3390\/ijms232113176","volume":"23","author":"M Heestermans","year":"2022","unstructured":"Heestermans M, Poenou G, Duchez AC, Hamzeh-Cognasse H, Bertoletti L, Cognasse F (2022) Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases. Int J Mol Sci 23(21):13176","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3315_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","volume":"9","author":"NM Bambace","year":"2011","unstructured":"Bambace NM, Holmes CE (2011) The platelet contribution to cancer progression. J Thromb Haemost 9(2):237\u2013249","journal-title":"J Thromb Haemost"},{"key":"3315_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/bcr3425","volume":"15","author":"I Lal","year":"2013","unstructured":"Lal I, Dittus K, Holmes CE (2013) Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res 15:207","journal-title":"Breast Cancer Res"},{"key":"3315_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123\u2013134","journal-title":"Nat Rev Cancer"},{"key":"3315_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20:576\u201390","journal-title":"Cancer Cell"},{"key":"3315_CR25","doi-asserted-by":"publisher","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","volume":"111","author":"M Labelle","year":"2014","unstructured":"Labelle M, Begum S, Hynes RO (2014) Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A 111:E3053\u2013E3061","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3315_CR26","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1007\/s00018-017-2536-7","volume":"74","author":"A Contursi","year":"2017","unstructured":"Contursi A, Sacco A, Grande R, Dovizio M, Patrignani P (2017) Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting. Cell Mol Life Sci 74:3491\u20133507","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3315_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","volume":"8","author":"M Haemmerle","year":"2017","unstructured":"Haemmerle M, Taylor ML, Gutschner T, Pradeep S, Cho MS, Sheng J, Lyons YM, Nagaraja AS, Dood RL, Wen Y, Mangala LS, Hansen JM, Rupaimoole R, Gharpure KM, Rodriguez-Aguayo C, Yim SY, Lee JS, Ivan C, Hu W, Lopez-Berestein G, Wong ST, Karlan BY, Levine DA, Liu J, Afshar-Kharghan V, Sood AK (2017) Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun 8:310","journal-title":"Nat Commun"},{"key":"3315_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.celrep.2018.03.092","volume":"23","author":"Y Ward","year":"2018","unstructured":"Ward Y, Lake R, Faraji F, Sperger J, Martin P, Gilliard C, Ku KP, Rodems T, Niles D, Tillman H, Yin J, Hunter K, Sowalsky AG, Lang J, Kelly K (2018) Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration. Cell Rep 23:808\u2013822","journal-title":"Cell Rep"},{"key":"3315_CR29","first-page":"338","volume":"3","author":"LJ Alberio","year":"2004","unstructured":"Alberio LJ, Clemetson KJ (2004) All platelets are not equal: COAT platelets. Curr Hematol Rep 3:338\u2013343","journal-title":"Curr Hematol Rep"},{"key":"3315_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1182\/blood-2013-11-539262","volume":"127","author":"V Tutwiler","year":"2016","unstructured":"Tutwiler V, Madeeva D, Ahn HS, Andrianova I, Hayes V, Zheng XL, Cines DB, McKenzie SE, Poncz M, Rauova L (2016) Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia. Blood 127:464\u201372","journal-title":"Blood"},{"key":"3315_CR31","unstructured":"Selvadurai M, Lee C, Yeung J, Konda M, Kershaw G, Favaloro E, Chen V (2020) Soluble platelet agonists expand the Procoagulant surface in Heparin-Induced thrombocytopenia. Session 311, American Society of Hematology Meeting"},{"key":"3315_CR32","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/jth.14008","volume":"16","author":"L Pasalic","year":"2018","unstructured":"Pasalic L, Wing-Lun E, Lau JK, Campbell H, Pennings GJ, Lau E, Connor D, Liang HP, Muller D, Kritharides L, Hogg PJ, Chen VM (2018) Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response. J Thromb Haemost 16:1198\u20131210","journal-title":"J Thromb Haemost"},{"key":"3315_CR33","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","volume":"27","author":"C Ay","year":"2009","unstructured":"Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, Drach J, Quehenberger P, Wagner O, Zielinski C, Pabinger I (2009) D-dimer and prothrombin fragment 1\u2009+\u20092 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 27:4124\u20134129","journal-title":"J Clin Oncol"},{"key":"3315_CR34","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R, Quehenberger P, Zielinski C, Pabinger I (2010) Prediction of venous thromboembolism in cancer patients. Blood 116:5377\u20135382","journal-title":"Blood"},{"key":"3315_CR35","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","volume":"6","author":"M Davila","year":"2008","unstructured":"Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, Baker CH, Francis JL (2008) Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6:1517\u20131524","journal-title":"J Thromb Haemost"},{"key":"3315_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/eci.12042","volume":"43","author":"J Thaler","year":"2013","unstructured":"Thaler J, Ay C, Mackman N, Metz-Schimmerl S, Stift J, Kaider A, M\u00fcllauer L, Gnant M, Scheithauer W, Pabinger I (2013) Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Eur J Clin Invest 43:277\u2013285","journal-title":"Eur J Clin Invest"},{"key":"3315_CR37","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood-2013-04-460147","volume":"122","author":"I Pabinger","year":"2013","unstructured":"Pabinger I, Thaler J, Ay C (2013) Biomarkers for prediction of venous thromboembolism in cancer. Blood 122:2011\u20132018","journal-title":"Blood"},{"key":"3315_CR38","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1055\/s-0042-1748193","volume":"48","author":"J Thachil","year":"2022","unstructured":"Thachil J, Favaloro EJ, Lippi G (2022) D-dimers-normal levels versus elevated levels due to a range of conditions, including d-dimeritis, inflammation, thromboembolism, disseminated intravascular coagulation, and COVID-19. Semin Thromb Hemost 48:672\u2013679","journal-title":"Semin Thromb Hemost"},{"key":"3315_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/MCA.0b013e328360efd3","volume":"24","author":"J Kaufmann","year":"2013","unstructured":"Kaufmann J, Wellnhofer E, Kappert K, Urban D, Meyborg H, Hauptmann T, M\u00fcller A, Meixner M, Graf K, Fleck E, Stawowy P (2013) Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention. Coron Artery Dis 24:312\u2013320","journal-title":"Coron Artery Dis"},{"key":"3315_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11239-019-01852-7","volume":"48","author":"SR McMahon","year":"2019","unstructured":"McMahon SR, Chava S, Taatjes-Sommer HS, Meagher S, Brummel-Ziedins KE, Schneider DJ (2019) Variation in platelet expression of Fc\u03b3RIIa after myocardial infarction. J Thromb Thrombolysis 48:88\u201394","journal-title":"J Thromb Thrombolysis"},{"key":"3315_CR41","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/17576180.2024.2395706","volume":"16","author":"DJ Schneider","year":"2024","unstructured":"Schneider DJ, Taatjes-Sommer HS, DiBattiste PM, Palla KS, Shovah T, Biswas S, Ohrnberger J (2024) Assessing prognosis by quantifying Fc\u03b3RIIa on fixed platelets. Bioanalysis 16:1025\u20131032","journal-title":"Bioanalysis"},{"key":"3315_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12551","volume":"5","author":"MU Ahmed","year":"2021","unstructured":"Ahmed MU, Receveur N, Janus-Bell E, Mouriaux C, Gachet C, Jandrot-Perrus M, Hechler B, Gardiner EE, Mangin PH (2021) Respective roles of Glycoprotein VI and Fc\u0263RIIa in the regulation of \u03b1IIb\u03b23-mediated platelet activation to fibrinogen, thrombus buildup, and stability. Res Pract Thromb Haemost 5:e12551","journal-title":"Res Pract Thromb Haemost"},{"key":"3315_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/09537104.2016.1148129","volume":"27","author":"CN Watson","year":"2016","unstructured":"Watson CN, Kerrigan SW, Cox D, Henderson IR, Watson SP, Arman M (2016) Human platelet activation by Escherichia coli: roles for Fc\u03b3RIIA and integrin \u03b1IIb\u03b23. Platelets 27:535\u2013540","journal-title":"Platelets"},{"key":"3315_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-9560-5-7","volume":"5","author":"FA Serrano","year":"2007","unstructured":"Serrano FA, El-Shahawy M, Solomon RJ, Sobel BE, Schneider DJ (2007) Increased platelet expression of FcGammaRIIa and its potential impact on platelet reactivity in patients with end stage renal disease. Thromb J 5:7","journal-title":"Thromb J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03315-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03315-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03315-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:16:40Z","timestamp":1786007800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03315-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03315-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"David J Schneider is named inventor on patents (US 10,502,737, US 11,747,335 B2) that propose the use of Fc\u0263RIIa for assaying platelet reactivity and treatment selection. Chris E Holmes and David J. Schneider are named inventors on a pending patent application that proposes use of Fc\u0263RIIa for assessing risk for venous thromboembolism and cancer progression. David J. Schneider is a founder of Prolocor.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol and consent were reviewed and approved by the University of Vermont Institutional Review Board.","order":2,"name":"Ethics","label":"Ethical considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participating subjects provided written informed consent.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}